BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 31513433)

  • 1. Antiviral immunity is impaired in COPD patients with frequent exacerbations.
    Singanayagam A; Loo SL; Calderazzo M; Finney LJ; Trujillo Torralbo MB; Bakhsoliani E; Girkin J; Veerati P; Pathinayake PS; Nichol KS; Reid A; Footitt J; Wark PAB; Grainge CL; Johnston SL; Bartlett NW; Mallia P
    Am J Physiol Lung Cell Mol Physiol; 2019 Dec; 317(6):L893-L903. PubMed ID: 31513433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced sputum expression of interferon-stimulated genes in severe COPD.
    Hilzendeger C; da Silva J; Henket M; Schleich F; Corhay JL; Kebadze T; Edwards MR; Mallia P; Johnston SL; Louis R
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1485-94. PubMed ID: 27418822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel immune genes associated with excessive inflammatory and antiviral responses to rhinovirus in COPD.
    Baines KJ; Hsu AC; Tooze M; Gunawardhana LP; Gibson PG; Wark PA
    Respir Res; 2013 Feb; 14(1):15. PubMed ID: 23384071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients.
    Menzel M; Akbarshahi H; Bjermer L; Uller L
    Sci Rep; 2016 Jun; 6():28698. PubMed ID: 27350308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired type I and type III interferon induction and rhinovirus control in human cystic fibrosis airway epithelial cells.
    Vareille M; Kieninger E; Alves MP; Kopf BS; Möller A; Geiser T; Johnston SL; Edwards MR; Regamey N
    Thorax; 2012 Jun; 67(6):517-25. PubMed ID: 22213737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Airway Epithelial Cell Immunity Is Delayed During Rhinovirus Infection in Asthma and COPD.
    Veerati PC; Troy NM; Reid AT; Li NF; Nichol KS; Kaur P; Maltby S; Wark PAB; Knight DA; Bosco A; Grainge CL; Bartlett NW
    Front Immunol; 2020; 11():974. PubMed ID: 32499788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A human rhinovirus model of chronic obstructive pulmonary disease exacerbations.
    Contoli M; Caramori G; Mallia P; Papi A; Johnston SL
    Contrib Microbiol; 2007; 14():101-112. PubMed ID: 17684335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human rhinovirus infection and COPD: role in exacerbations and potential for therapeutic targets.
    Cafferkey J; Coultas JA; Mallia P
    Expert Rev Respir Med; 2020 Aug; 14(8):777-789. PubMed ID: 32498634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human rhinovirus infection during naturally occurring COPD exacerbations.
    George SN; Garcha DS; Mackay AJ; Patel AR; Singh R; Sapsford RJ; Donaldson GC; Wedzicha JA
    Eur Respir J; 2014 Jul; 44(1):87-96. PubMed ID: 24627537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease.
    Mallia P; Footitt J; Sotero R; Jepson A; Contoli M; Trujillo-Torralbo MB; Kebadze T; Aniscenko J; Oleszkiewicz G; Gray K; Message SD; Ito K; Barnes PJ; Adcock IM; Papi A; Stanciu LA; Elkin SL; Kon OM; Johnson M; Johnston SL
    Am J Respir Crit Care Med; 2012 Dec; 186(11):1117-24. PubMed ID: 23024024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus.
    Wark PA; Johnston SL; Bucchieri F; Powell R; Puddicombe S; Laza-Stanca V; Holgate ST; Davies DE
    J Exp Med; 2005 Mar; 201(6):937-47. PubMed ID: 15781584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation.
    Mallia P; Message SD; Gielen V; Contoli M; Gray K; Kebadze T; Aniscenko J; Laza-Stanca V; Edwards MR; Slater L; Papi A; Stanciu LA; Kon OM; Johnson M; Johnston SL
    Am J Respir Crit Care Med; 2011 Mar; 183(6):734-42. PubMed ID: 20889904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lanosterol Synthase Regulates Human Rhinovirus Replication in Human Bronchial Epithelial Cells.
    McCrae C; Dzgoev A; Ståhlman M; Horndahl J; Svärd R; Große A; Großkopf T; Skujat MA; Williams N; Schubert S; Echeverri C; Jackson C; Guedán A; Solari R; Vaarala O; Kraan M; Rådinger M
    Am J Respir Cell Mol Biol; 2018 Dec; 59(6):713-722. PubMed ID: 30084659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD.
    Footitt J; Mallia P; Durham AL; Ho WE; Trujillo-Torralbo MB; Telcian AG; Del Rosario A; Chang C; Peh HY; Kebadze T; Aniscenko J; Stanciu L; Essilfie-Quaye S; Ito K; Barnes PJ; Elkin SL; Kon OM; Wong WS; Adcock IM; Johnston SL
    Chest; 2016 Jan; 149(1):62-73. PubMed ID: 25790167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD.
    Zhu J; Mallia P; Footitt J; Qiu Y; Message SD; Kebadze T; Aniscenko J; Barnes PJ; Adcock IM; Kon OM; Johnson M; Contoli M; Stanciu LA; Papi A; Jeffery PK; Johnston SL
    J Allergy Clin Immunol; 2020 Oct; 146(4):840-850.e7. PubMed ID: 32283204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How viral infections cause exacerbation of airway diseases.
    Mallia P; Johnston SL
    Chest; 2006 Oct; 130(4):1203-10. PubMed ID: 17035457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD.
    Quint JK; Donaldson GC; Goldring JJ; Baghai-Ravary R; Hurst JR; Wedzicha JA
    Chest; 2010 Apr; 137(4):812-22. PubMed ID: 19837822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease.
    Singh M; Lee SH; Porter P; Xu C; Ohno A; Atmar RL; Greenberg SB; Bandi V; Gern J; Amineva S; Aminev A; Skern T; Smithwick P; Perusich S; Barrow N; Roberts L; Corry DB; Kheradmand F
    J Allergy Clin Immunol; 2010 Jun; 125(6):1369-1378.e2. PubMed ID: 20430426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in systemic adaptive immunity contribute to the 'frequent exacerbator' COPD phenotype.
    Geerdink JX; Simons SO; Pike R; Stauss HJ; Heijdra YF; Hurst JR
    Respir Res; 2016 Oct; 17(1):140. PubMed ID: 27793198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD.
    Wilkinson TMA; Hurst JR; Perera WR; Wilks M; Donaldson GC; Wedzicha JA
    Chest; 2006 Feb; 129(2):317-324. PubMed ID: 16478847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.